Trials / Terminated
TerminatedNCT00620048
Stem Cell Study for Subjects With Congestive Heart Failure
Injection of Autologous CD34+ Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia and LVEF < 40%
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Losordo, Douglas, M.D. · Individual
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if cell therapy with your own cells (autologous cells) delivered with a catheter to regions of the heart with poor blood flow will be safe and if it will improve your ejection fraction and heart failure symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Intramyocardial injection of autologous CD34-positive cells (stem cells) | Comparison between a low dose and high dose of autologous (one's own) CD34-positive cells (stem cells) delivered via injections into the heart muscle. |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2011-01-01
- First posted
- 2008-02-21
- Last updated
- 2015-03-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00620048. Inclusion in this directory is not an endorsement.